UTILITY OF ASSESSMENT SERUM LEVELS OF VEGF, bFGF AND PDGF-BB AS SUGGESTED ANGIOGENESIS BIOMARKERS PANEL TOOL IN PATIENTS WITH BREAST CANCER
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2016, Vol 5, Issue 1
Abstract
Introduction: Breast cancer is the commonest cause of cancer death in women worldwide. A shift in the angiogenic balance allows the up-regulation of several pro-angiogenic factors, which by ways of mutual interactions stimulate tumor angiogenesis. Angiogenic factors are produced directly by tumor through the cancer cells or indirect by inflammatory cells that infiltrate tumor. Tumoural angiogenesis is essential for the growth and metastases of breast cancer cells. Aim: The aim of the present study was to asses vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF-BB) serum levels in breast cancer patients as promising suggested panel of tool of some angiogenesis markers assisted by Bio- Plex Pro assays for diagnosis and prognosis performance in breast cancer, also as predictors to identify subgroups of patients fitting into different treatment to improve clinical outcome Method: Serum samples were collected from 68 breast cancer female patients; 32 pre-treatment and 36 under conventional chemo-radiotherapy and 10 healthy female donors as controls. Under treatment patients classified according to therapy related number of cycles regimen received to 1-4 (n=10), 5-8 (n=18), and > 8 cycles (n=8). The levels of the angiogenic markers, VEGF, bFGF and PDGF-BB, were assessed by Bio-Plex Pro assays that quantify multiple protein biomarkers. Results: There was a significant increase in VEGF and PDGF-BB (P1< 0.05) and non significant elevated bFGF (p1>0.05) in breast cancer pretreatment patients compared to controls. In patients under treatment there was a non significant elevated level in median values for each marker than the base line measurement (P2 > 0.05). A highly significant reduction serum levels for each of bFGF and PDGF-BB (P3< 0.001) and significant reduction (P3< 0.05) for VEGF after conventional adjuvant therapy treatment compared with pretreated patient serum levels. Those patients received 1-4 cycles regimen elevated non-significant median values (P4 > 0.05) for each of FGF and PDGF-BB, while VEGF showed significant elevated serum level (P4 < 0.05) in compare to baseline measurement. Those patients received 5-8 cycles regimen treatment identified non significant reduction (P5 > 0.05) in median values with baseline level of control subjects. Those patient received more than 8 cycle regimen reviled significant reduction for bFGF (P6 < 0.05) and significant elevated value (P6 > 0.05) for VEGF and non-significant (P6 > 0.05) reduction serum level for PDGF-BB compared with base line measuring value. Conclusions: our results confirmed that suggested panel tool of VEGF, bFGF and PDGF-BB serum levels assessed by Bio-Plex ® Pro Assays for Angiogenesis Factors Quantification is useful for the early detection of breast cancer within screening programs, suitable for prospective studies for breast cancer diagnosis and/ or recurrence of tumor, in prognosis and monitoring members of high- risk breast cancer families. Also, our suggested panel angiogenesis marker tool is useful for identifying subgroups of patients fitting into different treatment to improve clinical outcome. Key words: Breast cancer; Bioplex; VEGF; bFGF; PDGF-BB
Authors and Affiliations
Nahla Anber
Keywords
Related Articles
- EP ID EP417988
- DOI -
- Views 117
- Downloads 0
HELLP SYNDROME: A BRIEF REVIEW
HELLP is an abbreviation of hemolysis (H), elevated liver enzyme (EL), and low platelet count (LP) which is a serious complication in pregnancy and also described as a severe form of preeclampsia and which is also associ...
Pre-formulation studies and Evaluation parameters of Bioadhesive Gel Incorporated Metronidazole Loaded Microspheres
Metronidazole is an antiprotozoal and antibacterial medication used mainly in the treatment of anaerobic bacteria. The preformulation studies were carried out in terms of tests for identification (physical appearance, me...
“STUDY OF DRUG UTILIZATION IN HOSPITAL PHARMACY & AT ITS INVENTORY CONTROL”
A study was conducted at Mahatma Gandhi Hospital Pharmacy Jaipur to study the inventory control of drug utilized for patient care, with a special focus on the drug expenditure. ABC,VED and ABC-VED matrix analysis techniq...
MicroRNAs in health and disease; a review of its multifaceted roles
A new class of noncoding small RNAs, called microRNAs (miRNAs), has emerged as important regulators in biological processes. The important role of miRNAs in inflammation and immune response is highlighted by studies in w...
In-Vitro Release Kinetics of Clonazepam from Five Brands of Clonazepam Available in Bangladesh Using UV Spectroscopic Analysis in Deionized Water Media
Background and Objective: The purpose of this study was to determine the in vitro release kinetics of five brands of Clonazepam tablets available in the local pharmaceutical market of Bangladesh. Methodology: In this stu...